StockData
NMTCNasdaqSurgical & Medical Instruments & ApparatusFiscal year ends September 30

NEUROONE MEDICAL TECHNOLOGIES Corp

Financials through Q3 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 13, 2026
$1.00+0.04 (+4.01%)

Close on Oct 19, 2026

Market cap
$8.74M
P/E (TTM)
–
Dividend yield
–

Earnings

Quarterly results announced on Form 8-K, Item 2.02

QuarterReportedTimeRevenueEPS (GAAP)EPS (adjusted)
Q3 FY2026
Ended Jun 30, 2026
Aug 13, 2026Before market open$2.00M$-0.28–
Q2 FY2026
Ended Mar 31, 2026
May 12, 2026Before market open$2.40M$-0.25–
Q1 FY2026
Ended Dec 31, 2025
Feb 17, 2026Before market open$2.90M––
Q4 FY2025
Ended Sep 30, 2025
Oct 6, 2025After market close–––
Q3 FY2025
Ended Jun 30, 2025
Aug 14, 2025Before market open–––
Q2 FY2025
Ended Mar 31, 2025
May 13, 2025Before market open–––
Q1 FY2025
Ended Dec 31, 2024
Jan 10, 2025Before market open–––
Q4 FY2024
Ended Sep 30, 2024
Dec 17, 2024Before market open–––
Q3 FY2024
Ended Jun 30, 2024
Aug 14, 2024After market close–––
Q2 FY2024
Ended Mar 31, 2024
May 14, 2024After market close–––
Q1 FY2024
Ended Dec 31, 2023
Feb 13, 2024After market close–––
Q4 FY2023
Ended Sep 30, 2023
Dec 14, 2023After market close–––

Company guidance

Outlook given with results on Aug 13, 2026, compared with the previous outlook

MeasurePeriodGuidancevs. prior
Recognized revenuefiscal year 2026$9.20M to $10.50MLowered

Figures and the sentence they come from are taken from the company's earnings release. Hover a measure to read the source sentence.

Press releases

Announcements Neuroone Medical Technologies filed with the SEC